Make us your home page

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Moffitt Cancer Center research improves treatment of advanced melanoma

TAMPA — A new cocktail of cancer-fighting drugs can help patients with advanced melanoma, a Moffitt Cancer Center researcher has reported in a study to be published in the New England Journal of Medicine.

The new research builds on recent advances in therapies for advanced melanoma that center on targeting its genetic fingerprint. Until recently, the deadly skin cancer was considered nearly untreatable in its later stages.

Drugs now are available that can block a mutation in a gene called BRAF, which fuels the cancer. The mutation is present in about half of melanoma cases. If caught early, lesions can be removed surgically, but doctors traditionally had few options once melanoma spreads throughout the body.

Dr. Jeffrey Weber, director of Moffitt's Melanoma Research Center of Excellence, was among the leaders of a national team that sought better results by combining drug therapies to inhibit the BRAF mutation and overcome the tumor's ability to grow resistant to the drugs.

The results of their complex study, involving about 250 patients, are now available online and will publish in print in the Nov. 15 edition of the prestigious New England Journal of Medicine.

Researchers found they could improve the outcome for patients through a combination of two drugs, dabrafenib and trametinib. Patients receiving the combination therapy saw their cancers go into remission for 9 1/2 months, compared to 5 1/2 months for those on dabrafenib, a BRAF inhibitor, alone.

Patients receiving the combination treatment also saw their tumors shrink at a higher rate than those receiving the single drug.

"This is an evolutionary development which has important implications," Weber said. "What this shows is you can, to some degree, reverse (drug) resistance."

Additionally, researchers saw more patients respond to the combination therapy. And fewer of them experienced common side effects, which can include additional (though less serious) skin cancers.

The research was funded by GlaxoSmithKline, which makes the two drugs. The study involved about two dozen researchers at major cancer centers in the United States and Australia.

Moffitt's Weber, one of five lead authors of the study, called it an important step in advancing drug therapies tailored to the unique genetic profile of each cancer patient.

"These are the first few steps in developing truly personalized medicine for melanoma," he said. "It's only going to get better from here."

Letitia Stein can be reached at or (727) 893-8330.

Moffitt Cancer Center research improves treatment of advanced melanoma 10/08/12 [Last modified: Monday, October 8, 2012 10:39pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times


Join the discussion: Click to view comments, add yours

  1. Miami woman, 74, admits to voter fraud. Does jail await, or will she go free?

    State Roundup

    MIAMI — An 74-year-old woman pleaded guilty Monday to filling out other people's mail-in ballots while working at Miami-Dade's elections department.

    Gladys Coego
  2. In Twitter rant, Bucs' Gerald McCoy says he's unappreciated


    Gerald McCoy is feeling underappreciated again. He says somebody has crossed the line this time. He's speaking out and suggesting he might be gone "soon enough" from Tampa Bay.

    Photo Illustration RON BORRESEN   |   Photo by LOREN ELLIOTT   |   Times 
Gerald McCoy may be upset that Ronde Barber said a defensive leader “has to have a huge personality’’ like Warren Sapp’s. Monday, Barber walked that back.
  3. Bigger ships carry Georgia ports to record cargo volumes

    Economic Development

    SAVANNAH, Ga. — Bigger ships arriving through an expanded Panama Canal pushed cargo volumes at Georgia's seaports to record levels in fiscal 2017, the Georgia Ports Authority announced Monday.

    The Port of Savannah moved a record 3.85 million container units in fiscal 2017, the state said, benefiting from the larger ships that can now pass through an expanded Panama Canal.
  4. Photo gallery: Nine years later, library attack victim Queena works at learning to walk again


    Slowly, Queena Phu is learning the act of walking again through exercises in locomotion, strength and balance.
    She practiced her steps once again Monday afternoon with trainer-technician Mike Lopez at the nonprofit Stay In Step Spinal Cord Injury Recovery Center near the University of South Florida.
    Queena …

    Activity based exercise trainer George Palang, 33, and trainer technician Mike Lopez, 22, help Queena Phu during physical therapy at the Stay In Step Spinal Cord Injury Recovery Center on Monday, July 24, 2017, in Tampa, Fla.
  5. Rays' Evan Longoria: "We have all the belief in the world in here"


    The weekend sweep by Texas and four-game overall losing streak has some Rays fans - based on their tweets and emails - questioning the team's ability to make the playoffs and suggesting they might as well trade away their key parts.